Profil Tech Stack

Full-service CRO specializing in early-phase diabetes and metabolic disease trials

Research Services Neuss 201–500 employees Founded 1999 Privately Held

Profil is a specialized contract research organization focused exclusively on diabetes and metabolic disease clinical trials, operating a 60-bed in-house clinical unit and maintaining a recruitment database of over 17,000 individuals with diabetes. Current hiring shows research and data roles accelerating alongside internal infrastructure projects—finance transformation, ERP implementation, and dataset integration—suggesting a shift from pure service delivery toward operational automation and data infrastructure maturity.

Tech Stack 11 technologies

Core StackWindows Server Linux Microsoft Exchange SQL Server Fortinet SQL Excel Microsoft Office Veeam HP Enterprise is not a standard product name. Did you mean "HPE" (Hewlett Packard Enterprise)? If you're referring to HPE as a company, I need a specific product name (like "HPE ProLiant", "HPE Synergy", etc.) Aruba

What Profil Is Building

◆Challenges

Integrating external datasets
Database lock coordination
Transforming finance processes
Automating invoice processing
Optimizing intercompany reconciliations
Contract quality and scalability
Vendor contract management

▲Active Projects

Data management plans creation
Ecrf development
Integration of external datasets
Finance transformation
Erp implementation
E-invoicing automation
Proposal management for individual studies
Process optimization within the department
Clinical study monitoring for diabetes phase i/ii

Hiring Activity

Accelerating9 roles · 8 in 30d

Department

Research

Sales

Data

Engineering

Finance

Healthcare

Ops

Seniority

Senior

Intern

Manager

Junior

Notable leadership hires: Head of Accounting

Company intelligence

Find more companies like Profil by tech stack, pain points and active projects

Get started free

About Profil

Profil GmbH, founded in 1999 as a spin-off from the University of Düsseldorf, operates as a full-service CRO with exclusive focus on diabetes and metabolic disease research. The company is ISO 9001 and 13485 certified and runs advanced clinical capabilities including automated glucose clamp studies, isotope dilution techniques, and muscle/fat biopsies. Its owned infrastructure—60-bed clinical facility, GMP-certified pharmacy, regulatory affairs department, and 17,000-person diabetes patient database—enables execution of Phase I–II trials on compressed timelines. The organization serves pharmaceutical sponsors developing anti-diabetic compounds and has contributed to development of major therapeutic classes in the field.

HeadquartersNeuss

Company Size201–500 employees

Founded1999

Hiring MarketsGermany

Frequently Asked Questions

What clinical research capabilities does Profil offer?

Profil specializes in Phase I–II diabetes and metabolic disease trials with proprietary methods: automated glucose clamps, isotope dilution techniques, muscle and fat biopsies, and pharmacodynamic characterization in early phases. Operates 60-bed in-house clinical unit in Neuss.

What is Profil's patient recruitment capacity?

Profil maintains a dedicated recruitment database of over 17,000 individuals with diabetes, enabling rapid subject enrollment for clinical studies without external recruitment dependencies.